Euvichol-S: WHO Approves New Oral Cholera Vaccine
The World Health Organization (WHO) recently approved Euvichol-S, a new oral cholera vaccine developed by EuBiologics Co., Ltd. in South Korea. Euvichol-S simplifies the formulation of the previous Euvichol-Plus vaccine while retaining its effectiveness, making production faster and more cost-effective. This approval comes amidst a global increase in cholera cases, where the vaccine’s simpler production could help alleviate the current strain on global vaccine supplies. In addition to vaccines, cholera management involves improving water, sanitation, and hygiene to comprehensively tackle outbreaks.
